Propionic Acid

Propionic Acid

SCHEMBL4154867

CCC(=O)O.O=c1[nH]c2ccc(S(=O)(=O)N3CCc4ccccc43)cc2c2cc[nH]c12

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.51
MAPT P10636 2/20 0.51
PKM P14618 2/20 0.51
GAA P10253 1/20 0.51
ALDH1A1 P00352 6/20 0.49
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
LMNA P02545 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
MAPK1 P28482 3/20 0.47
HTT P42858 2/20 0.47
BRD4 O60885 2/20 0.47
AKR1C3 P42330 1/20 0.46
AKR1C1 Q04828 1/20 0.46
NPSR1 Q6W5P4 1/20 0.45
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
STAT3 P40763 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4174097 0.82 HSD17B10 (0.55) TSHRMAPTGAAALDH1A1MEN1
Propionic Acid SCHEMBL4174066 0.82 KDM4E (0.54) TSHRMAPTGAAALDH1A1MEN1
Propionic Acid SCHEMBL4157681 0.80 GAA (0.54) TSHRMAPTPKMGAAALDH1A1
Propionic Acid SCHEMBL4155193 0.80 RXFP1 (0.41) MAPTALDH1A1MEN1KMT2AHTT
SCHEMBL4154862 0.79 PKM (0.49) TSHRMAPTPKMGAAALDH1A1
SCHEMBL3249322 0.79 MAPT (0.54) TSHRMAPTPKMGAAALDH1A1
SCHEMBL3250741 0.77 MAPT (0.55) TSHRMAPTPKMGAAALDH1A1
SCHEMBL3255459 0.77 MAPT (0.51) TSHRMAPTPKMGAAALDH1A1
Propionic Acid SCHEMBL4162918 0.77 BRAF (0.46) MAPT
Propionic Acid SCHEMBL4162521 0.77 FEN1 (0.44) TSHRMAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 TSHR 4040/4885MAPT 734/4885PKM 276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.